Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALS Untangled does not endorse the Wahls Protocol for slowing ALS

Original source

WAHLS ProtocolALSUntangled · 16 October 2024 (opens in a new tab)

ALS Untangled says there is no clinical-trial or case-report evidence that the Wahls diet changes ALS progression or survival. It concludes that the protocol should not be endorsed for slowing ALS because of concerns about weight loss and nutrient deficiencies.

Why this matters

People with ALS and their families should not assume that the Wahls Protocol slows the disease. The review says weight loss is linked with faster progression and shorter survival, so diets that cause weight loss or nutritional deficiencies may be concerning; this finding does not establish a treatment benefit or change current care.

Limitations and context

This is an independent expert review, not a new clinical trial. The evidence it discusses includes a cross-sectional study and a clinical trial in people with multiple sclerosis, rather than a trial testing ALS progression or survival. The review reports no ALS case reports or clinical trials showing benefit.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?